- ►annals.org [PDF] KAA Fox, JP Bassand, SR Mehta, L Wallentin, P … - Annals of Internal Medicine, 2007 - Am Coll Physicians Keith AA Fox, MBChB; Jean-Pierre Bassand, MD; Shamir R. Mehta, MD; Lars
Wallentin, MD, PhD; Pierre Theroux, MD; Leopoldo Soares Piegas, MD, PhD; Vicent
Valentin, MD; Tiziano Moccetti, MD; Susan Chrolavicius, BA; Rizwan Afzal, ... Cited by 14 - Related articles - BL Direct - All 2 versions
A Budaj, JW Eikelboom, SR Mehta, R Afzal, S … - European Heart Journal, 2009 - Eur Soc Cardiology Methods and results: Nine hundred and ninety (4.9%) patients developed major
bleeding and 423 (2.1%) developed minor bleeding. Fondaparinux compared with
enoxaparin reduced fatal bleeding [0.07 vs. 0.22%, relative risk (RR) 0.30, ... Cited by 13 - Related articles - All 3 versions
- ►oxfordjournals.org JP Bassand, CW Hamm - European Heart Journal, 2008 - Eur Soc Cardiology We read with great interest the letter by Bertrand et al. and appreciated their
positive comments about the recently published guidelines on management of
non-ST-segment elevation acute coronary syndromes, 1 especially concerning ... Related articles - BL Direct
K Meijer, S Schulman - Seminars in Thrombosis & Hemostasis, 2008 - thieme-connect.com The risk of bleeding associated with antithrombotic and fibrinolytic therapy
depends on factors that are specific for the drugs and the patients. In this
narrative review, we describe the most important risk factors for bleeding ... Related articles - All 4 versions
P ET, E INDÉSIRABLES, C INDICATION, I … - pgtm.qc.ca Récemment, quelques nouvelles publications ont mis en lumière l'utilisation
possible du fondaparinux pour le traitement des syndromes coronariens aigus
(SCA). A l'heure actuelle, les antithrombotiques parentéraux utilisés ... Related articles
FM Cardiology - medscape.com This activity is intended for cardiologists. It may also be of interest to
emergency department physicians, nurses, and other healthcare professionals who
are involved in the treatment and diagnosis of patients with ST-segment ... Related articles
SA Spinler, KW Mahaffey, D Gallup, GN … - International Journal of Cardiology, 2009 - Elsevier Of 9838 patients with a CrCl value, 70.6% (N = 6950) had CrCl ≥ 60 mL/min,
27.8% (N = 2732) had CrCl 30–59 mL/min, and 1.6% (N = 156) had CrCl < 30
mL/min. No randomized treatment by CrCl interaction test was found to be ... Cited by 1 - Related articles - All 2 versions
EM Antman - Nature Clinical Practice Cardiovascular Medicine, 2008 - nature.com Dr Elliott M Antman received his medical degree in 1974 from the College of
Physicians and Surgeons in New York City, NY, USA. He is the Director of the
Samuel A Levine Cardiac Unit at the Brigham and Women's Hospital and ... Cited by 1 - Related articles - BL Direct - All 3 versions
- ►cardiovascularpathology.com HD White, R Gallo, M Cohen, PG Steg, PE … - American heart journal, 2009 - canadiancpd.medscape.com Low-molecular-weight heparin (LMWH) is increasingly used as an alternative to
unfractionated heparin (UFH) for anticoagulation during percutaneous coronary
intervention (PCI). [1] Intravenous (IV) LMWH in elective PCI has been ... Cited by 1 - Related articles - All 40 versions
M Farooq, AS Qureshi, IB Squire - Expert Opin. Pharmacother., 2007 - informahealthcare.com The last two decades of the 20th century witnessed continuous evolution in the
understanding of the pathophysiology of ST elevation myocardial infarction. In
parallel, the management of these patients developed steadily throughout ... Cited by 1 - Related articles - BL Direct - All 4 versions
